Skip to main content
SpringerLink
Log in

Family Planning and Contraception

  • Reference work entry
  • First Online:
Family Medicine

  • 207 Accesses

Abstract

Ever since 1980, reducing unintended pregnancy has been a key goal of the Healthy People national health initiative. The unintended pregnancy rate in the United States (US) still remains one of the highest in the developed world. According to the latest National Survey of Family Growth (NSFG) study from 2010, nearly 49 % of the 6.7 million pregnancies in the USA were unintended in 2006 consistent with 52 unintended pregnancies for every 1,000 women aged 15–44 [1]. The outcome of these pregnancies has been remarkably stable over time, with 40 % eventuating in abortion as recently as 2008 [2]. Evidence in the literature suggests that unintended pregnancy poses both immediate and long-term adverse health risks for baby and mother, such as delayed prenatal care, poorer health in childhood, lower breastfeeding rates, and increased exposure to cigarette smoke [3]. Children born from unintended pregnancies are more likely to live in poverty, less likely to graduate high school and experience more behavioral problems in their teen years. These adverse outcomes are significantly amplified in the case of teen mothers, resulting in an average annual cost to US taxpayers from teen parenting estimated at $9.4 billion USD in 2010 [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 849.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Martinez G, Chandra A, Febo-Vazquez I, Mosher W. Use of family planning and related medical services among women aged 15–44 in the United States: National Survey of Family Growth, 2006–2010. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Center for Health Statistics; 2013. p. 1–17.

    Google Scholar 

  2. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84(5):478–85.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Trussell J. The cost of unintended pregnancy in the United States. Contraception. 2007;75(3):168–70.

    Article  PubMed  Google Scholar 

  4. Sd H. By the numbers: the public costs of teen childbearing. Washington, DC: National Campaign to Prevent Teen Pregnancy; 2006.

    Google Scholar 

  5. Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World Health Organization’s medical eligibility criteria for contraceptive use for use in the United States. Contraception. 2010;82(1):3–9.

    Article  PubMed  Google Scholar 

  6. Curtis KM, Tepper NK, Jamieson DJ, Marchbanks PA. Adaptation of the World Health Organization’s selected practice recommendations for contraceptive use for the United States. Contraception. 2013;87(5):513–6.

    Article  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention. U.S. Medical eligibility criteria for contraceptive use, 2010. MMWR Morb Mortal Wkly Rep. 2010;59:88.

    Google Scholar 

  8. Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The contraceptive CHOICE project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203(2):115 e111–7.

    Article  Google Scholar 

  9. Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project. Contraception. 2011;84(5):493–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. O’Neil-Callahan M, Peipert JF, Zhao Q, Madden T, Secura G. Twenty-four-month continuation of reversible contraception. Obstet Gynecol. 2013;122(5):1083–91.

    Article  PubMed  Google Scholar 

  11. Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012;120(6):1291–7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ott MA, Sucato GS, Committee on Adolescents. Contraception for adolescents. Pediatrics. 2014;134(4):e1257–81.

    Article  PubMed  Google Scholar 

  13. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2011;118(1):184–96.

    Article  Google Scholar 

  14. Randel A. Guidelines for the use of long-acting reversible contraceptives. Am Fam Physician. 2012;85(4):403–4.

    PubMed  Google Scholar 

  15. Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75(6 Suppl):S16–30.

    Article  CAS  PubMed  Google Scholar 

  16. Moyer DL, Mishell Jr DR. Reactions of human endometrium to the intrauterine foreign body. II. Long term effects on the endometrial histology and cytology. Am J Obstet Gynecol. 1971;111(1):66–80.

    Article  CAS  PubMed  Google Scholar 

  17. Center for Disease Control and Prevention (CDC). Update to CDC’s U.S. Medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR Morb Mortal Wkly Rep. 2012;61(24):449–52.

    Google Scholar 

  18. Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception. 1999;60(2):57–63.

    Article  CAS  PubMed  Google Scholar 

  19. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339(8796):785–8.

    Article  CAS  PubMed  Google Scholar 

  20. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev. 2001;1, CD001327.

    Google Scholar 

  21. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception. 1995;52(1):23–34.

    Article  CAS  PubMed  Google Scholar 

  22. Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol. 2007;50(4):907–17.

    Article  PubMed  Google Scholar 

  23. Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009;91(5):1646–53.

    Article  PubMed  Google Scholar 

  24. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71(4):306–8.

    Article  PubMed  Google Scholar 

  25. Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon study group. Hum Reprod. 1999;14(4):976–81.

    Article  CAS  PubMed  Google Scholar 

  26. Mishell DR. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41(suppl):381–90.

    CAS  PubMed  Google Scholar 

  27. Thurman AR, Hammond N, Brown HE, Roddy ME. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? J Pediatr Adolesc Gynecol. 2007;20(2):61–5.

    Article  PubMed  Google Scholar 

  28. Civic D, Scholes D, Ichikawa L, et al. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception. 2000;61:385–90.

    Article  CAS  PubMed  Google Scholar 

  29. Committee on Gynecologic Practice. Committee opinion no. 602: depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2014;123(6):1398–402.

    Article  Google Scholar 

  30. Yuzpe AA. Postcoital contraception. Clin Obstet Gynaecol. 1984;11(3):787–97.

    CAS  PubMed  Google Scholar 

  31. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352(9126):428–33.

    Article  Google Scholar 

  32. Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555–62.

    Article  CAS  PubMed  Google Scholar 

  33. Wu S, Godfrey EM, Wojdyla D, Dong J, Cong J, Wang C, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG. 2010;117(10):1205–10.

    Article  CAS  PubMed  Google Scholar 

  34. Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363–7.

    Article  CAS  PubMed  Google Scholar 

  35. Trusell J. Contraceptive efficacy. Contraceptive technology. 28th ed. New York: Ardent Media; 2007. p. 747–826.

    Google Scholar 

  36. Westhoff C, Heartwell S, Edwards S, Zieman M, Cushman L, Robilotto C, et al. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol. 2007;109(6):1270–6.

    Article  PubMed  Google Scholar 

  37. ACOG practice bulletin no. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115(1):206–18.

    Google Scholar 

  38. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin no. 73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2006;107(6):1453–72.

    Article  Google Scholar 

  39. Crosby RA, Charnigo RA, Weathers C, Caliendo AM, Shrier LA. Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect. 2012;88(7):484–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kennedy KI, Rivera R, McNeilly AS. Consensus statement on the use of breastfeeding as a family planning method. Contraception. 1989;39:477–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA

    Grant M. Greenberg & Allison Ursu

  2. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA

    Michael I. Hertz

Authors
  1. Grant M. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allison Ursu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael I. Hertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Grant M. Greenberg .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA

    Paul M. Paulman

  2. Department of Family and Community Medicine, Eastern Virginia Medical School, Norfolk, Virginia, USA

    Robert B. Taylor

  3. Department of Family Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA

    Audrey A. Paulman

  4. Department of Family Medicine, Creighton University School of Medicine, Omaha, Nebraska, USA

    Laeth S. Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this entry

Cite this entry

Greenberg, G.M., Ursu, A., Hertz, M.I. (2017). Family Planning and Contraception. In: Paulman, P., Taylor, R., Paulman, A., Nasir, L. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-04414-9_108

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04414-9_108

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04413-2

  • Online ISBN: 978-3-319-04414-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation